Skip to main content

Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.

Publication ,  Journal Article
Wray, R; Sheikhbahaei, S; Marcus, C; Zan, E; Ferraro, R; Rahmim, A; Subramaniam, RM
Published in: AJR Am J Roentgenol
September 2016

OBJECTIVE: This study investigates the prognostic value of (18)F-FDG PET/CT qualitative therapy assessment (Hopkins criteria) in patients with head and neck squamous cell carcinomas (HNSCCs) with residual neck nodes after definitive chemoradiation therapy and compares the Hopkins criteria with anatomic nodal size and morphologic features for prediction of survival outcomes. MATERIALS AND METHODS: A total of 72 patients with HNSCC, with negative primary tumor and positive residual neck nodes (CT criteria > 1 cm short-axis diameter) after the completion of definitive chemoradiation therapy, were included. PET/CT was performed 6-24 weeks after completion of treatment. FDG uptake in residual nodes on PET/CT was interpreted using a structured qualitative 5-point scale (Hopkins criteria). The 5-point scale was dichotomized to negative (scores 1, 2, and 3) or positive (scores 4 and 5) results. Cystic or necrotic nodes were defined as those with central low attenuation with a relatively hyperdense capsule. Kaplan-Meier curve and Cox regression analysis were performed. RESULTS: On the basis of the Hopkins criteria, 10 (13.9%) patients had positive findings and 62 (86.1%) had negative findings for residual nodal disease. According to CT interpretation, 25 patients (34.7%) had residual cervical lymph nodes greater than or equal to 1.5 cm in diameter, and 41 (56.9%) patients had cystic or necrotic nodes. Patients were followed for a median of 27 months after posttherapy PET/CT. There was a statistically significant difference in overall survival (OS) (hazard ratio, 7.06; p < 0.001) and progression-free survival (PFS) (hazard ratio, 6.18; p < 0.001) between patients with negative versus positive residual FDG nodal uptake. There was no statistically significant difference in OS and PFS in patients categorized on the basis of nodal size or morphologic features. CONCLUSION: PET-based structured qualitative therapy assessment (Hopkins criteria) can predict survival outcomes of patients with HNSCC with residual neck nodes after definitive chemoradiotherapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

September 2016

Volume

207

Issue

3

Start / End Page

641 / 647

Location

United States

Related Subject Headings

  • Survival Rate
  • Retrospective Studies
  • Radiopharmaceuticals
  • Prognosis
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Neoplasm, Residual
  • Middle Aged
  • Male
  • Lymphatic Metastasis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wray, R., Sheikhbahaei, S., Marcus, C., Zan, E., Ferraro, R., Rahmim, A., & Subramaniam, R. M. (2016). Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features. AJR Am J Roentgenol, 207(3), 641–647. https://doi.org/10.2214/AJR.15.15730
Wray, Rick, Sara Sheikhbahaei, Charles Marcus, Elcin Zan, Regan Ferraro, Arman Rahmim, and Rathan M. Subramaniam. “Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.AJR Am J Roentgenol 207, no. 3 (September 2016): 641–47. https://doi.org/10.2214/AJR.15.15730.
Wray R, Sheikhbahaei S, Marcus C, Zan E, Ferraro R, Rahmim A, et al. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features. AJR Am J Roentgenol. 2016 Sep;207(3):641–7.
Wray, Rick, et al. “Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.AJR Am J Roentgenol, vol. 207, no. 3, Sept. 2016, pp. 641–47. Pubmed, doi:10.2214/AJR.15.15730.
Wray R, Sheikhbahaei S, Marcus C, Zan E, Ferraro R, Rahmim A, Subramaniam RM. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features. AJR Am J Roentgenol. 2016 Sep;207(3):641–647.

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

September 2016

Volume

207

Issue

3

Start / End Page

641 / 647

Location

United States

Related Subject Headings

  • Survival Rate
  • Retrospective Studies
  • Radiopharmaceuticals
  • Prognosis
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Neoplasm, Residual
  • Middle Aged
  • Male
  • Lymphatic Metastasis